Theme: Regenerative Medicine Research: Showcasing the very real potential with recent results and outcomes

Regenerative Medicine 2018 America

Regenerative Medicine 2018 America

Details of Regenerative Medicine Conference 2018 in USA:

Conference Series LLC Ltd is organizing Regenerative Medicine Conferences in 2018 in Atlanta, USA. We organize Regenerative Medicine Meetings in the fields related to Cell Therapy, Stem Cell Research, Tissue Science and Engineering, Organ Regeneration and Regenerative Medicine in Oncology.

Conference Name	Place	Date
Regenerative Medicine Conference 2018	Atlanta, Georgia, USA	Nov 09-10, 2018

Conference Series LLC Ltd invites you to the City of Atlanta, USA for the “2nd Annual Summit on Cell Therapy and Regenerative Medicine” during November 09-10, 2018 which includes prompt Keynote Presentations, Oral Talks, Poster Presentations and Exhibitions. The Regenerative Medicine Conference is organized around the theme “Regenerative Medicine Research: Showcasing the very real potential with recent results and outcomes” which is designed to provide a platform for best discussions and networking as well as exploiting the new advancements related to the application of Cell Therapy and Regenerative Medicine in various fields of research and healthcare.

Importance and Scope:

Regeneration of organs was an ancient biology field that developed in the eighteenth century from the observations of limb regeneration in some of the lower animals. In the beginning of late twentieth century, a new term “regenerative medicine” was adapted to enhance our understanding of the correlations among various biotechnologies, including the parallel path of tissue engineering and its reliance on three pillars of technology: scaffolds, cells, and growth factors.

Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which “replaces or regenerates human cells, tissues or organs, to restore or establish normal function” and deploys small molecule drugs, biologics, medical devices and cell-based therapies.

This field continues to evolve. In addition to medical applications, non-therapeutic applications include using tissues as biosensors to detect biological or chemical threat agents and tissue chips that can be used to test the toxicity of an experimental medication. Cell therapy and Regenerative Medicine is the major field of Medicine, which is still under research and the advancements are maximizing day to day.

Regenerative Medicine 2018 will encompass recent researches, findings, cognizant discussions on novel subjects like Materials & Designs for Cell Therapy, Tissue Regeneration, Stem Cell–Tools to Battle Cancer, Bioreactors in Tissue Engineering, Regeneration & Therapeutics, Cord Blood & Regenerative Medicine and Clinical Medicine, to mention a few. The two days event implants a firm relation of upcoming strategies in the field of Cell Therapy & Regenerative Medicine with the scientific community from around the world. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations. Regenerative Medicine Conference brings together business, creative, and technology leaders from the healthcare, marketing, and research industry for the most current and relevant discussions, sharing knowledge and new advancement in the field.

We welcome you to Regenerative Medicine Conference, to be held on November 09-10, 2018 at Atlanta, USA. This conference presents information regarding cutting-edge developments in all areas of tissue engineering, stem cell research, regenerative medicine research including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, 3D printing of organs, cell-free regenerative medicine, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, and regulatory policies regarding stem cell research.

Target Audience:

· Eminent Scientists/Research Professors in the field of cell therapy and regenerative medicine

· Clinicians

· Junior/Senior research fellows

· Directors of Biopharma companies

· Members of different research associations

· Manufacturing medical devices companies

· Business entrepreneurs

· Medical colleges

· Industry professionals

· Diagnostic laboratory professionals

Track 1:Cell Therapy

The cell therapy branch of the regenerative medicine field has always been innovative in developing new models of delivery with the goal of improving many diseases. Cell therapy is, in effect, transplantation of human or animal cells to replace or repair damaged tissue and/or cells. During the procedure either whole fetal xenogenic cells or cell extracts from human tissue are injected into the patient. The latter method is known as autologous cell therapy if the cells injected are extracted from and transplanted back into the same patient. Several different types of cells can be administered simultaneously. In addition to blood transfusion cell therapy in the form of bone marrow transplant has been conducted for decades which are utilized for the treatment of several types of blood disorders including anemia, leukemia, lymphoma and rare immunodeficiency diseases. Claims have been made by the proponents of cell therapy that it has been used successfully to treat various other diseases too. However, we need to cross many hurdles when it comes to connecting modern cell therapies with the established drug development and sales methodologies.

10th World Congress and Expo on Cell & Stem Cell Research March 19-21, 2018 New York, USA; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London,UK; Cell Therapy Manufacturing & Gene Therapy Congress 6 - 7 December 2017 RAI, Amsterdam; 25th World Congress on Cancer Science and Therapy October 18-20, 2017 Baltimore, Maryland, USA; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; Cell & Gene Therapy World event 2018, 22-25 January 2018 Hyatt Regency, Miamiâ€‹â€‹â€‹â€‹â€‹â€‹â€‹; Combined CAR-T Congress Europe January 30-31, 2018 Berlin, Germany

Track 2:Regenerative Medicine

Regenerative Medicine refers to a group of biomedical approaches to research and clinical applications which is aimed at replacing or "regenerating" human cells, tissues or organs to restore or establish normal functions which were damaged due to diseases. The field of Regenerative medicine has attracted much attention as it holds the promise of regenerating damaged tissues and organs in the body by replacing damaged tissue or by stimulating the body's own repair mechanisms to heal damaged tissues or organs. It also may enable scientists to grow tissues and organs in the laboratory and safely implant them within the body. Regenerative solutions thus can be a revolutionary step in the field of healthcare.

9th International Conference on Tissue Science and Regenerative Medicine July 19-20, 2018 Melbourne, Australia; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan; ICTERMA 2018: 20th International Conference on Tissue Engineering and Regenerative Medicine Applications May 10-11, 2018, Amsterdam; BIT’s 11th World Congress of Regenerative Medicine and Stem Cell November 14-16, 2017 Singapore; International Translational and Regenerative Medicine Conference April 25-27, 2018 Rome, Italy; Regenerative Biology and Applications: Cell Differentiation, Tissue Organization and Biomedical Engineering 15–19 Oct 2017 Pok Fu Lam, Hong Kong; 7th International Conference on Tissue Engineering & Regenerative Medicine October 02-04, 2017 Barcelona, Spain; World Congress on Organ Transplantation and Artificial Organs April 23-24, 2018 Dubai, UAE; ICRMRE 2018 : 20th International Conference on Regenerative Medicine, Regulation and Ethics January 29 - 30, 2018 Sydney, Australia

Track 3:Stem Cells

Stem cells are the fundamental units for achieving regenerative therapies thus these cells are gaining research and experimental focus for therapeutic screening as well as other interventions. The two most useful characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. One of the most celebrated successes witnessed in use of stem cells in the field of regenerative medicine is the clinical implementation of bone marrow transplantation for regeneration of the blood-forming system.

10th World Congress and Expo on Cell & Stem Cell Research March 19-21, 2018 New York, USA; 9th Annual Conference on Stem Cell and Regenerative Medicine Sep 25-26, 2017 Berlin, Germany; Stem Cells, Aging and Rejuvenation 06–10 Nov 2017 Suzhou, China; Stem Cells: The Next generation 10-12 Nov 2017 Guangzhou, China; EuroSciCon Conference on StemCell April 16-17, 2018 Amsterdam, Netherlands; 12th World Hematologists Congress March 15-16, 2018 London, UK; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain

Track 4:Mesenchymal stem cells (MSC)

Mesenchymal stromal cells have emerged as powerful tool for regenerative medicine field. Mesenchymal stem cells (MSCs) are a population of multipotent progenitor cells residing in bone marrow, fat, and some other tissues and can be isolated from various adult and fetal tissues.

Stem Cells: The Next generation 10-12 Nov 2017 Guangzhou, China;10th World Congress and Expo on Cell & Stem Cell Research March 19-21, 2018 New York, USA; 9th Annual Conference on Stem Cell and Regenerative Medicine Sep 25-26, 2017 Berlin, Germany; Stem Cells, Aging and Rejuvenation 06–10 Nov 2017 Suzhou, China; EuroSciCon Conference on StemCell April 16-17, 2018 Amsterdam, Netherlands; 12th World Hematologists Congress March 15-16, 2018 London, UK; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain

Track 5:Stem Cell Transplantation

Stem cell transplantation is a procedure in which diseased bone marrow (the spongy, fatty tissue found inside larger bones) is destroyed with chemotherapy and/or radiation therapy and then replaced with highly specialized stem cells that develop into healthy bone marrow. It is most often recommended as a treatment option for people with leukemia, multiple myeloma, and some types of lymphoma. It may also be used to treat some genetic diseases that involve the blood. Although this procedure used to be referred to as a bone marrow transplant, today it is more commonly called a stem cell transplant because it is stem cells in the blood that are typically being transplanted, not the actual bone marrow tissue.

World Congress on Organ Transplantation and Artificial Organs April 23-24, 2018 Dubai, UAE; Stem Cells: The Next generation 10-12 Nov 2017 Guangzhou, China;10th World Congress and Expo on Cell & Stem Cell Research March 19-21, 2018 New York, USA; 9th Annual Conference on Stem Cell and Regenerative Medicine Sep 25-26, 2017 Berlin, Germany; Stem Cells, Aging and Rejuvenation 06–10 Nov 2017 Suzhou, China; EuroSciCon Conference on StemCell April 16-17, 2018 Amsterdam, Netherlands; 12th World Hematologists Congress March 15-16, 2018 London, UK; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain

Track 6:Tissue Engineering and Regenerative Medicine

Tissue engineering is widely used in the biomedical sector for regeneration and repair of diseased or trauma tissues. Tissue engineering addresses tissue and organ failure by implanting natural, synthetic, or semisynthetic tissue and organ mimics that are fully functional from the start or that grow into the required functionality. The field initially focused on skin equivalents for treating burns, but an increasing number of tissue types are now being engineered, as well as biomaterials and scaffolds are being used as delivery systems successfully. A variety of approaches are used to coax differentiated or undifferentiated cells, such as stem cells, into the desired cell type.

20th Global Congress on Biotechnology March 5-7, 2018 London, UK; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Synthetic Biology and Tissue Engineering June 11-12, 2018 Rome, Italy; Global Summit on Stem Cell & Tissue Engineering July 23-24, 2018 at Barcelona, Spain; 2018 TERMIS World Congress September 4-7, 2018 Kyoto, Japan; ICTEB 2018: 20th International Conference on Tissue Engineering and Biomaterials February 19 - 20, 2018 Paris, France; ICBTE 2018 : 20th International Conference on Biomaterials and Tissue Engineering January 18 - 19, 2018 London, United Kingdom

Track 7:Biologic Scaffolds for Regenerative medicine

Scaffolds are one of the three most important elements constituting the basic concept of regenerative medicine, and are included in the core technology of regenerative medicine. Every day thousands of surgical procedures are performed to replace or repair tissue that has been damaged through disease or trauma. The developing field of tissue engineering (TE) aims to regenerate damaged tissues by combining cells from the body with highly porous scaffold biomaterials, which act as templates for tissue regeneration, to guide the growth of new tissue. Scaffolds has a prominent role in tissue regeneration the designs, fabrication, 3D models, surface ligands and molecular architecture, nanoparticle-cell interactions and porous of the scaffolds are been used in the field in attempts to regenerate different tissues and organs in the body.

10th Symposium on Biologic Scaffolds for Regenerative Medicine March 03-05, 2018 Napa, CA, USA; 3rd Annual Conference and Expo on Biomaterials March 05-06, 2018 Berlin, Germany; 4th International Conference on Synthetic Biology and Tissue Engineering June 11-12, 2018 Rome, Italy; 20th Global Congress on Biotechnology March 5-7, 2018 London, UK; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan; ICBE 2018 : 20th International Conference on Biomaterials Engineering May 21 - 22, 2018 Berlin, Germany; International Conference on Biomaterials August 16-18, 2018, London, UK;

Track 8:Immunotherapy

Due to rapidly advancing field of cancer immunology in past few years, there has been production of several new methods of treating cancer called Immunotherapies. Immunotherapy is a type of treatment that increases the strength of immune response against tumors either by stimulating the activities of specific components of immune system or by counteracting signals produced by cancer cells that suppress immune responses. Some types of immunotherapy are also called as biologic therapy or biotherapy. Recent advancements in cancer immunotherapies have provided new therapeutic approaches. These include tumor-associated macrophages as treatment targets in oncology, in-situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy, immune checkpoint blockade and associated endocrinopathies and many more.

10th Global Summit on Immunology and Cell biology May 28-29, 2018 Osaka, Japan; 12th International Conference on Allergy, Asthma & Clinical Immunology October 1-2, 2018 Moscow, Russia; 9th Molecular Immunology & Immunogenetics Congress March 08-09, 2018 London, UK; 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy September 17-18, 2018 San Diego, USA; 9th European Immunology Conference June 14-16, 2018 Rome, Italy; World Immunotherapy Congress 2018 May 23 - 24 Hilton San Diego Resort and Spa, San Diego USA; 5th Immunotherapy of Cancer Conference (ITOC5) 19 - 21 March 2018 Mercure Hotel MOA, Berlin, Germany; ICTII 2018 : 20th International Conference on Tumor Immunology and Immunotherapy January 29 - 30, 2018 Sydney, Australia; Cancer Immunotherapy: Combinations March 23—27, 2018 Fairmont The Queen Elizabeth, Montreal, Québec, Canada

Track 9:Gene Therapy

Gene therapy uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. Several approaches to gene therapy are currently being tested by the researchers including: Replacing a mutated gene that causes disease with a healthy copy of the gene; Inactivating or “knocking out” a mutated gene that is functioning improperly; Introducing a new gene into the body to help fight a disease. Although gene therapy is a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections), the technique remains risky and is still under study to make sure that it will be safe and effective. Gene therapy is currently only being tested for diseases that have no other cures.

3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 4th World Conference on Synthetic Biology and Genetic Engineering Nov 9-10, 2017 Singapore; 3rd World Congress on HUMAN GENETICS September 24-25, 2018 Berlin, Germany; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; Cell & Gene Therapy World event 2018, 22-25 January 2018 Hyatt Regency, Miamiâ€‹â€‹â€‹â€‹â€‹â€‹â€‹; 3rd International Conference on Molecular Medicine and Diagnostics April 23-24, 2018 Dubai, UAE; 4th World Congress On Protein and Bio-Medical Engineering March 15-17,2018 Singapore;

Track 10:Models of Regeneration

Researchers are developing animal models to study various aspects of regenerative medicine such as stem cell repopulation, recellularization, cellular mechanisms underlying limb and spinal cord regeneration etc.

Track 11:Orthopedics, Sports Medicine and Regenerative Rehabilitation

Regenerative medicine attempts to augment the natural healing process to heal or even “grow back” the damaged tissue viz. muscle, tendon, ligament or cartilage etc. Surgical and non-surgical procedures are performed which are designed specifically to heal and “Regenerate” damaged tissues.

ICRR 2018 : 20th International Conference on Regenerative Rehabilitation November 29 - 30, 2018 Melbourne, Australia; 4th International Conference and Exhibition on Pain Medicine October 19-20, 2017 San Francisco, California, USA; 11th World Congress on Orthopedics, Rheumatology & Sports Medicine July 09-11, 2018 Sydney, Australia; 5th International Conference and Expo on Novel Physiotherapies March 19-20, 2018 Berlin, Germany; 7th World Congress on Physical Medicine and Rehabilitation May 24-25, 2018 Osaka, Japan; 8th International Conference on World Physiotherapists & Physicians Summit; Regenerative Rehabilitation 2017 (6th Annual International Symposium on Regenerative Rehabilitation) Nov 01 – 03, 2017Pittsburgh, United States

Track 12:Regenerative Medicine in Aging, Dermatology and Plastic Surgery

People with reconstructive needs due to aging, burn injuries, cancer, complex wounds, birth anomalies and other trauma have very limited effective treatment options. Researchers and plastic surgeons are creating regenerative medicine therapies with the goal of both healing the damaged tissue as well as forming new tissue.

17th European Dermatology Congress March 1-3, 2018 Paris, France; 15th International Conference on Clinical and Experimental Dermatology August 30-31, 2018 Toronto, Ontario, Canada; 13th Global Dermatologists Congress Aug 13-14, 2018 Madrid, Spain; Asia-Pacific conference on Dermatology and Cosmetology August 22-23, 2018 Tokyo, Japan;

Track 13:Biomaterials and Bioprocessing

Regenerative Medicine is growing and maturing steadily; however, there are many challenges that lie ahead. These include best cell source, most appropriate biomaterials, and reliable ways of expanding the cells and growing them in a three-dimensional environment (stem cell bioprocessing).

3rd Annual Conference and Expo on Biomaterials March 05-06, 2018 Berlin, Germany; 4th International Conference on Synthetic Biology and Tissue Engineering June 11-12, 2018 Rome, Italy; 20th Global Congress on Biotechnology March 5-7, 2018 London, UK; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan;

Track 14:Cell Therapy and Cryopreservation

Cell therapies with short shelf-life due to a “fresh” final product (as the product is not designed for long-term storage) are perfectly acceptable for proof of concept of the cell therapy. But when it enters late-stage development and then commercial production, different constraints arise. Thus a cryopreserved final product becomes a necessity when considering the possibility of a late-stage clinical or commercial product with potentially thousands of doses a year that are needed to be shipped to different hospitals all over a continent or the world.

Track 15:Clinical Trials on cell therapy and Regenerative medicine

Clinical trials are research studies carried out with human subjects to evaluate the effects of health-related interventions on health-related biomedical or behavioral outcomes.

12th Global Pharmacovigilance & Clinical Trials Summit; 6th International Conference on Advanced Clinical Research and Clinical Trials September 10-11, 2018 Zurich, Switzerland; 7th International Conference on Clinical Trials September 24-25, 2018 Chicago, USA; 7th International Conference on Clinical and Medical Case Reports April 16-17, 2018 Dubai, UAE; 6th International Conference on Clinical & Medical Case Reports October 16-18, 2017 San Francisco, California, USA

Track 16:Translational Research

Translational research involves future clinical application of the ongoing regenerative medicine and cell therapy studies.

ICSCN 2018 : 20th International Conference on Stem Cells in Neurology February 22 - 23, 2018 Mumbai, India; 25th World Cancer Conference Oct 19-21, 2017 Rome, Italy; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany

Track 17:Criticisms and Challenges

Cell therapies, stem cell therapies and regenerative medicine have faced much criticism from scientists, researchers, bioethicists. Much has been talked about the field but very small is done for resolving these issues.

ICRMRE 2018 : 20th International Conference on Regenerative Medicine, Regulation and Ethics January 29 - 30, 2018 Sydney, Australia; International Conference on Biobetters and Regulatory Implications June 25-26, 2018 Vancouver, Canada; 20th Global Congress on Biotechnology March 5-7, 2018 London, UK; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain;

Track 18:Cell Therapy and Regenerative Medicine Market

North America has become the global leader in cell therapy market with 50 percent share in the global market as heavy investments are being made for the development and commercialization of cell therapy products. The regenerative medicine market in Asia-Pacific is growing at a faster rate as a result of the intensified Research and Development activity in Japan and South Korea. Governments of some countries like Canada, Japan, and the United States are creating programs, establishing centers of excellence, manufacturing infrastructure and research networks to facilitate the rapid and profitable commercialization of these products in order to reduce the cost of care for aging population. However, the market is hindered to some extent as viable manufacturing infrastructure that supports the mass production of quality regenerative medicine products is still lacking. Therefore, large-scale manufacturing units are needed for autologous cell therapy and combination therapy products to meet the growing market demand.

With all the recent chaos made in the field of regenerative medicine and stem cell therapy regarding its abuse, overblown promises and potential applicability, Conference Series LLC Ltd is providing a platform with Regenerative Medicine Congress-2018 with a goal of fulfilling the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need as well as for discussing the well-meant criticisms required for building consensus in a field which has become a regulatory battleground.

The global market for regenerative medicine is expected to reach $30,237 million by the year 2022 with cell therapy segment dominating the market throughout the forecast period.

Treatments based on various cell types have long been proclaimed for their potential to drive the future of regenerative medicine thus have inspired medical and business interests in this field.

On the basis of technology, regenerative medicine market can be segmented into four categories.

1. Cell therapy

2. Gene therapy

3. Tissue engineering

4. Small molecules and biologics

World regenerative medicine market by technology, 2015–2022 ($million) (1) The global market for stem cell therapy has been expanding since 2012. The global stem cell market was estimated at $5.9 billion in the year 2015 and reached over $6.87 billion in 2016. It is expected to reach about $12.3 billion in 2021, at an impressive compound annual growth rate (CAGR) of 13.1% from 2016 through 2021. One of the major segments of regenerative medicine boosting the market growth is Tissue Engineering and Organ Regeneration. The global market for tissue engineering and regeneration is rising at a compound annual growth rate (CAGR) of 34.9% and is expected to reach $60.8 billion by 2021 from $13.6 billion in 2016. The U.S. market for regenerative medicine products for only bone and joint application is projected to reach nearly $4.1 billion by 2020 growing at annual growth rate (CAGR) of 6.8% from 2.9 billion in 2015. The regenerative medicine materials market can be segmented into three broad categories. 1. Synthetic Materials 2. Biological materials 3. Genetically Engineered Materials Synthetic and biologically derived materials have high market demand due to their high efficiency and better outcome during the procedures. Among regenerative medicine products synthetic polymers play a key role as they are developed for the use of three-dimensional extracellular microenvironments in tissue and organ-specific differentiation and morphogenesis. The synthetic materials which are being used in tissue engineering hold promising potential in the regenerative medicine market in terms of revenue. Regenerative medicine market by region: In the year 2015, North America accounted for highest market (bone & joint regenerative medicine) share globally representing a market value of $2,039.8 million and is expected to grow at annual growth rate (CAGR) of 32.5% from 2016 to 2022. Due to increasing end-use applications in North America, this region has proven to be the most attractive market for regenerative medicine products and services. As most of the therapies are in the late-stage clinical trials, the North American regenerative medicine market is expected to reach new heights in terms of revenue in the near future. Favorable regulatory and reimbursement policies for tissue engineering act as a catalyst in fulfilling the growing demand of regenerative products. However, stringent regulatory policies for stem cell technologies have posed major challenges in this field thereby restricting the market growth. Europe is the second largest market for regenerative medicine, which is expected to grow at a CAGR of 31.2% whereas market in Asia-Pacific region is growing at a CAGR of 39.9%. As favorable government initiatives are being taken in Asian countries like China and India, it has paved the way for regenerative medicine market in these countries. Adoption of these treatment methods in developed countries of Asia-Pacific like Japan and South Korea is also fuelling the regenerative medicine market. The increase in awareness among the healthcare professionals and patients regarding the benefits of regenerative medicine in the recent years has increased the demand significantly. Increasing capital investments, market growth rates, revenues, all these financial data reflect a field which is expected to exhibit high potential in future and will demand more time, focus and capital to mature. The market analysis report for regenerative medicine is relevant to clinicians, researchers, investors, biotechnology and pharmaceutical companies who wish to quantify the potential in this field. Major players in the market: Integra Lifesciences California Stem Cell Inc Acelity Holdings, Inc. Stryker Corporation Zimmer Biomet Holdings, Inc. Medtronic plc Baxter International, Inc. DePuy Synthes Organogenesis, Inc. (Advanced Biohealing) Acelity Holdings, Inc. Ocata Therapeutics, Inc. CryoLife, Inc. Major Regenerative Medicine Associations around the Globe: International Stem Cell Forum (ISCF) California Institute for Regenerative Medicine International Society for Stem Cell Research (ISSCR) UK Medical Research Council (MRC) Australian Stem Cell Center Canadian Institutes of Health Research (CIHR) Euro Stem Cell (ACR) Center for Stem Cell Biology Stem Cell Research Singapore UK National Stem Cell Network

Known as the "Capital of the New South," Atlanta is a prospering metropolis and a great place to visit. Fueled by the investment of globally-headquartered "local" corporations like Coca Cola and Holiday Inn, it's home to "the most trusted name in news," CNN, host to the 1996 Summer Olympic Games, and welcoming to the migration of the young creative class who have flocked to the city.

Some of the key reasons why Atlanta, Georgia has been chosen for the conference-

  Georgia is a home to world-class research organizations and technological resources with clusters of bioscience companies located predominantly in the metro Atlanta.

  The life sciences department is a potent economic force in Georgia, with a large concentration of bio-occupational employment including more than 27,000 researchers and scientists.

  Georgia’s research partnerships foster bioscience research and its commercialization.

  Georgia is becoming a hub for healthcare IT companies.

 Georgia’s state government has invested hundreds of millions of dollars in the state’s universities to support the scientists in pursuit of research discoveries and early commercialization of technologies.

  Bio-pharma companies in Georgia are often eligible for a variety of tax credits as well as for sales tax exemptions thus providing them a pro-business environment.



Renowned research Institutions in Georgia:

U.S. Centers for Disease Control and Prevention (CDC)

Georgia Institute of technology

Emory University

University of Georgia

Georgia State University

Augusta University

Clark Atlanta University

Morehouse School of Medicine

Yerkes National Primate Research Center

Center for Behavioral Neuroscience

Regenerative Medicine 2016

5th International Conference on Tissue Engineering and Regenerative Medicine was organized during September 12-14, 2016 at Berlin, Germany. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

Regenerative Medicine Conference was based on the theme “Advanced Approaches in Stem Cell and Regenerative Medicine” which included the following scientific tracks:

Translational Medicine

Bone Tissue Engineering

Models of Regeneration

Regenerative Medicine

Scaffolds in Regenerative Medicine

Stem Cells

Tissue Repair and Regeneration

Rejuvenation

Cell Engineering

Tissue Engineering

Cell and Organ Regeneration

Regenerative Medicine Market

Stem Cell Treatments

Cellular Therapies

Gene Therapies

Immunotherapy

Biomaterials and Bioengineering

Stem Cell Transplant

Ethical and Legal Issues

Embryonic Stem Cell

Regenerative Medicine Europe

The Organizing Committee would like to thank the moderators Dr. Scott L. Nyberg, Mayo Clinic, USA (Day 1), Bipasha Bose, Yenepoya University, India (Day 2) and Elisa Maillard, University of Strasbourg, France (Day 3) for their contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Werner Mohl- Hemodynamic activation of vascular cells in cardiac veins induce an equivalent of stimulus triggered acquired pluripotency in human cardiomyocytes

Barritault Denis- Extra cellular matrix micro-environment control is a key issue to regenerative medicine and RGTA based matrix therapy a solution

Bertha Chen- The role of regenerative medicine in Obstetrics and Gynecology

Pedro Morouço- Novel scaffolds fabrication methods in regenerative medicine: The cartilage challenge

Conference Series LLC Ltd has taken the privilege of felicitating Regenerative Medicine -2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Regenerative Medicine 2016. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Tissue Science & Engineering: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, Conference Series LLC Ltd would like to proudly announce the commencement of the "2nd Annual Summit on Cell Therapy and Regenerative Medicine" to be organized this time in U.S.A. during November 09-10, 2018 at Atlanta, Georgia.

Regenerative Medicine 2017

Will be updated soon!

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 9-10, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

2nd Annual Summit on ^{Cell Therapy, Tissue Science and Regenerative Medicine} November 9-10, 2018 Atlanta, Georgia, USA

Recommended Global Genetics & Molecular Biology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Regenerative Medicine 2018 America

Details of Regenerative Medicine Conference 2018 in USA:

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues